Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
IFC lending $147.5M to Jubilant Pharma
International Finance Corporation (IFC), a member of the World Bank Group, is lending $147.5 million (Rs 865 crore) to Jubilant ......
Healthcare
Andhra HC lifts stay on Sun Pharma-Ranbaxy merger
The Andhra Pradesh High Court has vacated its stay order on the proposed merger of Ranbaxy Laboratories Ltd with Sun ......
Healthcare
Quadria-backed hospital chain Medica Synergie aims to triple its capacity in a year
Kolkata-headquartered hospital chain Medica Synergie Pvt Ltd, which is building up its presence in eastern region of the country, aims ......
Healthcare
SeQuent acquiring assets and business of Arvee Synthesis
Bangalore-based SeQuent Scientific Limited has entered into a definite agreement to acquire the manufacturing assets and business of Arvee Synthesis ......
Healthcare
VC-backed Mitra Biotech spruces up flagship diagnostic product
Bangalore-based Mitra Biotech Pvt Ltd, which focuses on personalised cancer care and rational drug development, has rebranded and is now ......
Healthcare
What's driving dental chain business in India
Single speciality segment has been one of the hottest areas within the broader healthcare sector. Indeed, one clear driver for ......
Healthcare
US FDA finds Sun Pharma's response to import ban inadequate
US drug regulator has said that Sun Pharma’s response to the ban on imports of products made at one of ......
Healthcare
Biomark Capital-backed Strand Life Sciences may float IPO by 2016
Bangalore-based Strand Life Sciences Pvt Ltd, which focuses on clinical genomics and research in biotechnology, aims to go for public ......
Healthcare
Mires puts total fair valuation of Dr Datsons at $60M
European pharma player Mires B.V has completed its valuation exercise as part of its interest to acquire majority stake in ......
Healthcare
AstraZeneca rejects Pfizer's final offer worth $118B
British drug maker AstraZeneca has rejected the fourth and final takeover offer worth $118 billion by Pfizer Inc on Monday ......
